Intervention: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
Found 17 matching trials
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
PHASE4
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification
PHASE3
This study was designed to evaluate the effectiveness and safety of hepatic...
A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors
NA
This study aims to explore the value of the 'HAIC Apatinib Camrelizumab' tr...